Skip to main content
OpenTrials
Completed

NCT Number: NCT05727566

Sexual Dysfunction in Patients With Myofascial Pain Syndrome

This study evaluates the frequency of sexual dysfunction in women with myofascial pain syndrome and its relationship with clinical parameters.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–50 year

Sex eligibility

Female

Study type

Observational

Primary location

University of Health Sciences, Konya Beyhekim Training and Research Hospital, Department of Physical Medicine and Rehabilitation

Konya, 42060, Turkey (Türkiye)

About this study

The frequency of sexual dysfunction in reproductive-aged married women with primary myofascial pain syndrome will be evaluated in a prospective, cross-sectional survey-type study. The medical history of each participant was obtained and they underwent a detailed physical examination. Sociodemographic and clinic characteristics of all participants (age, education, marital status, employment status, family structure, income status, Body Mass Index(BMI), disease duration, number of pregnancies, sleep quality, etc.) were recorded. Pain and fatigue levels of the patients were measured by the visual pain scale (VAS), mood states by the Beck depression index (BDI), sexual function of the participants was assessed by the 0-10 Visual Analog Scale (VAS) to assess the degree of importance of sexuality (the sexuality-importance score). In addition, weekly/monthly sexual intercourse frequency was asked to all participants (patient and control groups). The questionnaires were administered to all participants in a room where they were alone with a female physician, and a suitable environment was provided for the patients to fill out the questionnaire. Patients were assured of the confidentiality of their information. Only questions that were not understood by the patient were explained without guidance.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Myofascial pain syndrome (>3 months) was diagnosed in a female.
  • Being between the ages of 18 and 50, married, sexually active, and not menopausal
  • Volunteering to participate in the study, and being able to communicate easily.

Exclusion criteria

  • a history of systemic disease (cardiovascular, pulmonary, hepatic, renal, hematological, etc.)
  • major psychiatric illness, mental retardation
  • uncontrollable respiratory system problems
  • endocrine diseases, neurological diseases
  • previous hysterectomy or vaginal surgery, a history of sexually transmitted diseases
  • urinary or anal incontinence
  • limited motion in the upper or lower extremities
  • Fibromyalgia
  • inflammatory rheumatic diseases (such as rheumatoid arthritis, ankylosing spondylitis, etc.)
  • cervical/lumbar radiculopathy or myelopathy
  • communication problems
  • pregnancy, lactation
  • taking estrogen therapy
  • use antidepressant, anxiolytic, and antiepileptic drugs
  • chronic alcohol users

Treatment and study plan

visual pain scale (VASpain/fatigue), Beck depression index (BDI), the sexuality-importance score, sexual intercourse frequency

Other

visual pain scale (VASpain/fatigue), Beck depression index (BDI), the sexuality-importance score, sexual intercourse frequency

Primary outcomes

  1. Sexuality-importance score

    Time frame: 11.05.2022-15.03.2023 (cross-sectional)

    Sexual function of the participants was assessed by the 0 (never mind)-10(very important) Visual Analog Scale (VAS) to assess the degree of importance of sexuality.

  2. The frequency of sexual intercourse

    Time frame: 11.05.2022-15.03.2023 (cross-sectional

    Weekly/monthly sexual intercourse frequency was asked of all participants.

Secondary outcomes

  1. Visual analog scale (VAS pain/fatigue)

    Time frame: 11.05.2022 - 15.03.2023 (cross-sectional)

    All participants were assessed in terms of pain and fatigue levels by means of a visual analogue scale of 0-10 cm (VAS).

  2. Beck depression index (BDI)

    Time frame: 11.05.2022 - 15.03.2023 (cross-sectional)

    In the assessment of depression severity, the Turkish version of the 21-item Beck Depression Inventory (BDI) was used, which is one of the most common psychometric tests used and a value of 0 to 3 is assigned for each answer to each item.

Sponsors and collaborators

Lead sponsor

Konya Beyhekim Training and Research Hospital

Other Gov

Registry information

Important dates

Study start
2022
Primary completion
2023
Study completion
2023
First posted
Feb 14, 2023
Registry last updated
May 13, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.